Increased risk of pulmonary tuberculosis in patients with gastroesophageal reflux disease
- PMID: 26792483
- DOI: 10.5588/ijtld.15.0251
Increased risk of pulmonary tuberculosis in patients with gastroesophageal reflux disease
Abstract
Background: Previous studies have suggested a close correlation between gastroesophageal reflux disease (GERD) and various respiratory disorders. However, the association between GERD and tuberculosis (TB) remains unexplored.
Methods: Using data retrieved from Taiwan's National Health Insurance Research Database from 2000 to 2009, this longitudinal nationwide cohort study included a total of 63,930 patients with GERD and controls matched by age, sex and comorbidities. Risk factors associated with the development of pulmonary TB (PTB) were investigated.
Results: Active PTB was documented in 65 (0.20%) patients with GERD and 41 (0.13%) matched cohorts within 1 year of GERD diagnosis. The incidence rate of PTB in the GERD group and the matched cohort was respectively 24.1 and 15.2 cases per 10,000 person-years. In multivariate analysis, GERD was an independent risk factor for PTB (adjusted HR 1.63, 95%CI 1.10-2.40, P = 0.015). Among patients with GERD, independent predictors for PTB included older age, male sex, chronic obstructive pulmonary disease, asthma and exposure to proton pump inhibitors (PPIs).
Conclusion: Patients with GERD have a significantly increased risk of PTB within 1 year of GERD diagnosis. Exposure to PPIs is an independent predictor for PTB among patients with GERD.
Similar articles
-
Patients with Cerebral Stroke Have an Increased Risk of Gastroesophageal Reflux Disease: A Population-Based Cohort Study.J Stroke Cerebrovasc Dis. 2018 May;27(5):1267-1274. doi: 10.1016/j.jstrokecerebrovasdis.2017.12.001. Epub 2018 Jan 8. J Stroke Cerebrovasc Dis. 2018. PMID: 29325919
-
Proton pump inhibitors use is associated with a lower risk of acute exacerbation and mortality in patients with coexistent COPD and GERD.Int J Chron Obstruct Pulmon Dis. 2018 Sep 19;13:2907-2915. doi: 10.2147/COPD.S157761. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30275689 Free PMC article.
-
Healthcare costs of GERD and acid-related conditions in pediatric patients, with comparison between histamine-2 receptor antagonists and proton pump inhibitors.Curr Med Res Opin. 2009 Nov;25(11):2703-9. doi: 10.1185/03007990903307755. Curr Med Res Opin. 2009. PMID: 19775195
-
Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.Br J Clin Pharmacol. 2015 Aug;80(2):200-8. doi: 10.1111/bcp.12619. Epub 2015 Jun 11. Br J Clin Pharmacol. 2015. PMID: 25752807 Free PMC article. Review.
-
Gastroesophageal reflux disease in chronic obstructive pulmonary disease.Respir Investig. 2024 Sep;62(5):746-758. doi: 10.1016/j.resinv.2024.06.004. Epub 2024 Jun 27. Respir Investig. 2024. PMID: 38941760 Review.
Cited by
-
Association of gastroesophageal reflux disease with the incidence of pulmonary disease.Front Cell Dev Biol. 2025 Jul 23;13:1552126. doi: 10.3389/fcell.2025.1552126. eCollection 2025. Front Cell Dev Biol. 2025. PMID: 40772230 Free PMC article.
-
Is There a Potential Link between Gastroesophageal Reflux Disease and Recurrent Respiratory Tract Infections in Children?Diagnostics (Basel). 2023 Jul 7;13(13):2310. doi: 10.3390/diagnostics13132310. Diagnostics (Basel). 2023. PMID: 37443704 Free PMC article.
-
The human proton pump inhibitors inhibit Mycobacterium tuberculosis rifampicin efflux and macrophage-induced rifampicin tolerance.Proc Natl Acad Sci U S A. 2023 Feb 14;120(7):e2215512120. doi: 10.1073/pnas.2215512120. Epub 2023 Feb 10. Proc Natl Acad Sci U S A. 2023. PMID: 36763530 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical